Interviews with the world’s key opinion leaders in cancer

TagOlaparib

Christian Singer MD: Neoadjuvant Olaparib Combination Beats Standard of Care in Patients with Homologous Recombination Deficient BRCA 1/2-Positive Triple-Negative Breast Cancer

10 months ago

Audio Journal of Oncology, August 5th, 2025 An interview with: Christian Singer MD, Head, Center for Breast Health, Department of Obstetrics &...

November 2, 2018

Audio Journal of Oncology Podcast First Line PARP Inhibition For Ovarian Cancer Assessed Play Episode Pause Episode Mute/Unmute Episode Rewind 10...

November 1, 2018

Audio Journal of Oncology Podcast BRCA1/2 Ovarian Cancer—Three Years Disease Free with First-Line Olaparib Play Episode Pause Episode...